BN three-lens brief
Evidence-based stock research on BN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 15.7pp over 30 days. · P/E of 78 — priced for high growth; little margin of safety.
- Outperforming SPY by 15.7pp over 30 days.
- P/E of 78 — priced for high growth; little margin of safety.
- Analyst mean target $54.65 — 30% above current (10 analysts).
- Negative free cash flow last quarterly (-$1.98B).
- Reported earnings on 2026-11-12.
BN closed at $42.06 (-0.78%) as of 2026-11-12. Market cap: $93.89B. P/E (trailing) 77.9. Price is above the 50-day MA and below the 200-day MA. Positives: outperforming SPY by 15.7pp over 30 days.; analyst mean target $54.65 — 30% above current (10 analysts).. Concerns: p/E of 78 — priced for high growth; little margin of safety.; negative free cash flow last quarterly (-$1.98B).. Last quarter: Revenue $1.61B, free cash flow -$1.98B. Watching for: 2026-11-12 earnings release (today).
Why three lenses on BN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BN across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/BN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BN brief"></iframe>